The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor

Current Biology

Volumn 8, Issue 6, 1998, Pages 335-340

  Shapiro, Lawrence ^a   Scherer, Philipp E ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032510463     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(98)70133-2     Document Type: Article

References (29)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
2. Hu E, Liang P, Spiegelman BM: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996, 271:10697-10703.
3. Clas F, Loos M: Antibody-independent binding of the first component of complement (C1) and its subcomponent C1q to the S and R forms of Salmonella minnesota. Infect Immun 1981, 31:1138-1144.
4. Clas F, Golecki JR, Loos M: Electron microscopic study showing antibody-independent binding of C1q, a subcomponent of the first component of complement, to serum-sensitive salmonellae. Infect Immun 1984, 45:795-797.
5. Alberti S, Marques G, Hernandez-Alles S, Rubires X, Tomas JM, Vivanco F, Benedi VJ: Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36. Infect Immun 1996, 64:4719-4725.
6. Reid KB: Chemistry and molecular genetics of C1q. Behring Inst Mitt 1989:8-19.
7. Reid KB, Day AJ: Ig-binding domains of C1q. Immunol Today 1990, 11:387-388.
8. Kaul M, Loos M: Collagen-like complement component C1q is a membrane protein of human monocyte-derived macrophages that mediates endocytosis. J Immunol 1995, 155:5795-5802.
9. Tracey KJ, Cerami A: Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994, 45:491-503.
10. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M: Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 1996, 120:803-812.
11. Jones EY, Stuart DI, Walker NP: Structure of tumour necrosis factor. Nature 1989, 338:225-228.
12. Eck MJ, Sprang SR: The structure of tumor necrosis factor-α at 2.6 Å resolution. Implications for receptor binding. J Biol Chem 1989, 264:17595-17605.
13. Weis WI, Quesenberry MS, Taylor ME, Bezouska K, Hendrickson WA, Drickamer K: Molecular mechanisms of complex carbohydrate recognition at the cell surface. Cold Spring Harb Symp Quant Biol 1992, 57:281-289.
14. Weis WI, Drickamer K: Trimeric structure of a C-type mannose-binding protein. Structure 1994, 2:1227-1240.
15. Brass A, Kadler KE, Thomas JT, Grant ME, Boot-Handford RP: The fibrillar collagens, collagen VIII, collagen X and the C1q complement proteins share a similar domain in their C-terminal non- collagenous regions. FEBS Lett 1992, 303:126-128.
16. Duncan AR, Winter G: The binding site for C1q on IgG. Nature 1988, 332:738-740.
17. Marques G, Anton LC, Barrio E, Sanchez A, Ruiz S, Gavilanes F, Vivanco F: Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G. J Biol Chem 1993, 268:10393-10402.
18. Nedwin GE, Naylor SL, Sakaguchi AY, Smith D, Jarrett-Nedwin J, Pennica D, et al.: Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res 1985, 13:6361-6373.
19. Sellar GC, Blake DJ, Reid KB: Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q. Biochem J 1991, 274:481-490.
20. Renshaw BR, Fanslow WCR, Armitage RJ, Campbell KA, Liggitt D, Wright B, et al.: Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 1994, 180:1889-1900.
21. Naismith JH, Sprang SR: Tumor necrosis factor receptor superfamily. J Inflamm 1995, 47:1-7.
22. Kulics J, Circolo A, Strunk RC, Colten HR: Regulation of synthesis of complement protein C4 in human fibroblasts: cell- and gene-specific effects of cytokines and lipopolysaccharide. Immunology 1994, 82:509-515.
23. Kawakami Y, Watanabe Y, Yamaguchi M, Sakaguchi H, Kono I, Ueki A: TNF-alpha stimulates the biosynthesis of complement C3 and factor B by human umbilical cord vein endothelial cells. Cancer Lett 1997, 116:21-26.
24. Hotamisligil GS, Spiegelman BM: Tumor necrosis factor α: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
25. Teoman Uysal K, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 1997, 389:610-614.
26. Takamatsu N, Ohba K, Kondo J, Kondo N, Shiba T: Hibernation-associated gene regulation of plasma proteins with a collagen-like domain in mammalian hibernators. Mol Cell Biol 1993, 13:1516-1521.
27. Flier JS, Cook KS, Usher P, Spiegelman BM: Severely impaired adipsin expression in genetic and acquired obesity. Science 1987, 237:405-408.
28. Depraetere V, Golstein P: Fas and other cell death signaling pathways. Semin Immunol 1997, 9:93-107.
29. Karpusas M, Hsu YM, Wang JH, Thompson J, Lederman S, Chess L, Thomas D: 2 Å crystal structure of an extracellular fragment of human CD40 ligand Structure 1995, 3:1031-1039.